Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Dermatologic 1Breast 1

Conditions

Sarcoma 1Mycosis Fungoides 1Melanoma 1Carcinoma, Squamous Cell 1Carcinoma, Merkel Cell 1Breast Neoplasms 1

Interventions

Flow Cytometry 4Therapeutics 3Psychiatric Rehabilitation 3Polymerase Chain Reaction 3liposomal amphotericin B 2Radiotherapy 2Ondansetron 2Itraconazole 2Immunoenzyme Techniques 2Dexamethasone 2Cyclophosphamide 2Caspofungin 2Calcium Dobesilate 2Aprepitant 2Amplified Fragment Length Polymorphism Analysis 2trastuzumab biosimilar HLX02 1temsirolimus 1talimogene laherparepvec 1sargramostim 1romidepsin 1pembrolizumab 1obinutuzumab 1motexafin gadolinium 1liposomal doxorubicin 1flt3 ligand protein 1entinostat 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1copanlisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mycosis Fungoides × TTI-621 × Breast × Clear all
NCT02890368 2023-04-05

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Pfizer

Phase 1 Terminated
56 enrolled
BreastDermatologicLymphoidSarcoma

Breast Neoplasms, Carcinoma, Squamous Cell, Melanoma, Mycosis Fungoides, Sarcoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡